Vaxil Bio Stock Analysis
| VXL Stock | CAD 0.01 0.00 0.00% |
Vaxil Bio is overvalued with Real Value of 0.0084 and Hype Value of 0.01. The main objective of Vaxil Bio stock analysis is to determine its intrinsic value, which is an estimate of what Vaxil Bio is worth, separate from its market price. There are two main types of Vaxil Bio's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Vaxil Bio's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Vaxil Bio's stock to identify patterns and trends that may indicate its future price movements.
The Vaxil Bio stock is traded in Canada on TSX Venture Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Canada. Vaxil Bio is usually not traded on Canada Day, Civic Holiday, Labour Day, Christmas Day, Boxing Day, New Year 's Day, Family Day, Good Friday, Victoria Day. Vaxil Stock trading window is adjusted to America/Toronto timezone.
Vaxil |
Vaxil Stock Analysis Notes
The book value of the company was at this time reported as 0.01. The company had not issued any dividends in recent years. Vaxil Bio had 1:2 split on the 10th of March 2016. Vaxil Bio Ltd., an immunotherapy biotech company, engages in the research and development of immunotherapies for cancer and infectious diseases in Israel. The company was founded in 2006 and is headquartered in Toronto, Canada. VAXIL BIO is traded on TSX Venture Exchange in Canada. For more information please call Yuval Avnir at 416-227-9667 or visit https://www.vaxil-bio.com.Vaxil Bio Investment Alerts
| Vaxil Bio generated a negative expected return over the last 90 days | |
| Vaxil Bio has some characteristics of a very speculative penny stock | |
| Vaxil Bio has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (254 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| Vaxil Bio has accumulated about 307 K in cash with (561 K) of positive cash flow from operations. | |
| Latest headline from news.google.com: Vaxil Bio 14-Day RSI 41.18 - GuruFocus.com |
Vaxil Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 1.37 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Vaxil Bio's market, we take the total number of its shares issued and multiply it by Vaxil Bio's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Vaxil Profitablity
Vaxil Bio's profitability indicators refer to fundamental financial ratios that showcase Vaxil Bio's ability to generate income relative to its revenue or operating costs. If, let's say, Vaxil Bio is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Vaxil Bio's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Vaxil Bio's profitability requires more research than a typical breakdown of Vaxil Bio's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
| Last Reported | Projected for Next Year | ||
| Return On Capital Employed | (0.29) | (0.30) |
Management Efficiency
Vaxil Bio has return on total asset (ROA) of (0.1018) % which means that it has lost $0.1018 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.2026) %, meaning that it generated substantial loss on money invested by shareholders. Vaxil Bio's management efficiency ratios could be used to measure how well Vaxil Bio manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.0003 in 2024. Return On Capital Employed is likely to drop to -0.3 in 2024. At this time, Vaxil Bio's Net Tangible Assets are fairly stable compared to the past year. Non Currrent Assets Other is likely to climb to about 88 K in 2024, whereas Total Assets are likely to drop slightly above 853.8 K in 2024.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 0.01 | 0.01 | |
| Tangible Book Value Per Share | 0.01 | 0.01 | |
| Enterprise Value Over EBITDA | (9.79) | (9.30) | |
| Price Book Value Ratio | 3.84 | 2.90 | |
| Enterprise Value Multiple | (9.79) | (9.30) | |
| Price Fair Value | 3.84 | 2.90 | |
| Enterprise Value | 1.1 M | 1.1 M |
Leadership effectiveness at Vaxil Bio is a strong indicator of its financial stability. We analyze various metrics to provide insights into the stock's investment viability.
Beta (3.67) | Return On Assets (0.10) | Return On Equity (0.20) |
Technical Drivers
In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Vaxil Bio, as well as the relationship between them.Vaxil Bio Price Movement Analysis
The output start index for this execution was thirteen with a total number of output elements of fourty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Vaxil Bio middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Vaxil Bio. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Vaxil Bio Outstanding Bonds
Vaxil Bio issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Vaxil Bio uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Vaxil bonds can be classified according to their maturity, which is the date when Vaxil Bio has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View |
About Vaxil Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Vaxil Bio prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Vaxil shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Vaxil Bio. By using and applying Vaxil Stock analysis, traders can create a robust methodology for identifying Vaxil entry and exit points for their positions.
| Last Reported | Projected for Next Year |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Vaxil Bio to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Equity Analysis Now
Equity AnalysisResearch over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |
| All Next | Launch Module |
Additional Tools for Vaxil Stock Analysis
When running Vaxil Bio's price analysis, check to measure Vaxil Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaxil Bio is operating at the current time. Most of Vaxil Bio's value examination focuses on studying past and present price action to predict the probability of Vaxil Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaxil Bio's price. Additionally, you may evaluate how the addition of Vaxil Bio to your portfolios can decrease your overall portfolio volatility.